ANDHealth is a unique non-profit industry-led organisation focused on strengthening the Australian digital health ecosystem and de-risking innovations in digital health, with a focus on clinical evidence, commercialisation and investment readiness.
ANDHealth’s vision is to create a world leading, national, integrated ecosystem for the development, commercialisation and implementation of evidence-based digital health technologies in Australia.
The ANDHealth+ program is focused on assisting Australian mid-stage digital health companies to meet key investor, partner and customer requirements around clinical and commercial validation. The inaugural ANDHealth+ program has delivered over $1.8 million in value of which only 13 per cent was cash.
The remainder was in-kind generated via ANDHealth’s member and ecosystem partner network. For every dollar invested in cohort company projects $7.55 of value was created and made available to the companies.
Outcomes: The 10 ANDHealth+ cohort companies have raised $16.6M in dilutive and non-dilutive funding in FY2021, with 47 projects launched and 98 jobs recruited this year. ANDHealth has continued to be supported by the TTRA and REDI programs.
|Consortium lead|| |
|Consortium members|| |
Murdoch Children's Research Institute, Novartis Pharmaceuticals, RMIT University, Planet Innovation, Curve Tomorrow, Allens, Potential(x), HealthXL, HPM Executive & AusBiotech
|Project duration||June 2017 - December 2019 (Completed)|
|Contact||Bronwyn Le Grice - email@example.com|
DownloadANDHealth's “Digital Health: Creating a New Growth Industry for Australia” report.